Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
Abstract Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at adv...
Guardado en:
Autores principales: | L. E. Anselmino, M. V. Baglioni, F. Malizia, N. Cesatti Laluce, C. Borini Etichetti, V. L. Martínez Marignac, V. Rozados, O. G. Scharovsky, J. Girardini, M. J. Rico, M. Menacho Márquez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93cfc863cbba48eda474cd3a9008e6b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of intralesional propranolol for periocular capillary hemangioma
por: Awadein A, et al.
Publicado: (2011) -
Development and characterization of a nanoemulsion containing propranolol for topical delivery
por: Zanela da Silva Marques T, et al.
Publicado: (2018) -
Propranolol en el Tratamiento de los Hemangiomas de la Infancia
por: KRÄMER H,DANIELA, et al.
Publicado: (2010) -
Hemangioma subglótico tratado con propranolol: Una nueva alternativa terapéutica. Caso clínico
por: OSORIO M,JAIME, et al.
Publicado: (2013) -
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro.
por: Nichole Orr-Burks, et al.
Publicado: (2021)